Factors influencing the switch from tamoxifen to aromatase inhibitors as adjuvant therapy in early breast cancer patients. Results from the NORA Study / P., Pronzato; Me, Cazzaniga; Mustacchi, Giorgio. - 24 (18S):(2006), pp. 18S-18S. ( ASCO Meeting).
Factors influencing the switch from tamoxifen to aromatase inhibitors as adjuvant therapy in early breast cancer patients. Results from the NORA Study
MUSTACCHI, GIORGIO
2006-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


